Understanding Envelope Function in HIV-1 Infection: The Design, Synthesis and Validation of Small Molecule HIV-1 Env Inhibitors
Understanding Envelope Function in HIV-1 Infection: The Design, Synthesis and Validation of Small Molecule HIV-1 Env Inhibitors
批准号:
10471375
负责人:
Amos B Smith
金额:
$30.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 2024-08-31
关键词:
AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAffinityAnti-Retroviral AgentsAntibodiesBindingBinding SitesBiologicalBiological AssayCD4 AntigensCalorimetryCellsCollaborationsComputer ModelsCryoelectron MicroscopyCrystallizationDataFreedomGlycoproteinsGoalsHIVHIV Envelope Protein gp120HIV antiretroviralHIV-1InfectionInterventionKnowledgeLabelLaboratoriesLeadLibrariesLigandsMass Spectrum AnalysisMeasurementMolecular ConformationNaturePharmacologyPhotoaffinity LabelsPlayPreventionProcessProductionProteinsResolutionRoentgen RaysRoleSideSiteStructureStructure-Activity RelationshipTitrationsValidationViralVirionVisualizationaffinity labelinganalogantagonistantibody-dependent cell cytotoxicitybasecrosslinkdesigndesign verificationenantiomerhigh throughput screeninginhibitorinsightmimeticsmodel designneutralizing antibodypandemic diseaseprogramsrational designscaffoldscreeningsingle-molecule FRETsmall moleculesmall molecule inhibitorsugartool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Understanding Env Function in HIV-1 Infection:
The Design, Synthesis and Validation of Small Molecule HIV-1 Env Inhibitors
Project 3: Summary:
The Central Goal of this Program Project (P0-1-GM-06550) comprises the identification and understanding of
the functional states of the HIV-1 envelope (Env) trimer: (a) in the standalone virion; (b) during the HIV-1 cell
entry process; and (c) during the process of antibody dependent cellular cytotoxicity (ADCC) of HIV-1 infected
cells. Specifically we propose to design, synthesize and validate small molecules that bind to the HIV-1 Env
glycoproteins (gp120 and gp41), and in turn modulate the HIV-1 Env functional states. Such an objective will
require the accumulation of knowledge regarding the nature and function of the Env trimer at the highest
possible level of atomic resolution. The derived understanding in turn will permit the design and synthesis of
effective HIV-1 virion inactivators, cell entry inhibitors and ADCC sensitizers of HIV-1 infected cells, which hold
the promise for both the prevention and eradication of HIV/AIDS. The specific targeted compounds,
anticipated to bind the CD4 binding pocket, to other regions of the gp120 subunit and/or to the gp41 subunit,
will arise through the close collaborative use of smFRET studies (Program 1), crosslinking-mass spectrometry,
inhibitor binding bioassay data (Projects 2, 4 and Core B), high-resolution X-ray/cryoEM structures (Project 5
and collaborator Pamela Björkman) and computational modeling (Core A). Importantly, the recent
technological advances in cryoEM and smFRET trimer visualization, in conjunction with biological
measurements (Projects 1, 2, 4 and Core B), will permit elucidation of the specific effects that small molecule
Env modulators have on the function of the HIV-1 Env. As such, the efforts of the P01 will clearly aid in the
design and validation of new pharmacological tactics to address the AIDS pandemic.
Project 3, The Synthetic Thrust of this Program Project, will focus specifically on the Program Project
goals by developing and validating new classes of small molecules that interact uniquely with the HIV-1 Env
trimer (gp120 and gp41), thereby providing insights into the landscape of Env conformations (i.e., Env states)
and their biological implications. The close collaboration that has and will continue to occur between each of
the five Program Projects and two Cores will clearly enhance the discovery, design, and validation of more
highly functional, broad spectrum small molecule inhibitors/ADDC sensitizers of HIV-1 infected cells, as well as
lead to labeled probes to identify, stabilize and/or modulate the important Env conformational changes leading
to cell entry and/or infected cell eradication. Thus, through high throughput screens, computational modeling,
design, and synthesis, along with structural analysis (smFRET/crystal/cryoEM) and bioassay/binding validation
measurements, Project 3 will play a central, highly focused role in this Program Project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dictyostatin and related prodrugs as candidates for tauopathy treatment
-
批准号:8821175
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:Amos B Smith
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:8008963
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2010
-
负责人:Amos B Smith
-
依托单位:
Alzhelmer's Disease Drug Development Program
-
批准号:7676129
-
项目类别:
-
资助金额:$64.07万
-
财政年份:2008
-
负责人:Amos B Smith
-
依托单位:
Alzhelmer's Disease Drug Development Program
-
批准号:7525036
-
项目类别:
-
资助金额:$63.32万
-
财政年份:2008
-
负责人:Amos B Smith
-
依托单位:
Alzhelmer's Disease Drug Development Program
-
批准号:8118501
-
项目类别:
-
资助金额:$60.96万
-
财政年份:2008
-
负责人:Amos B Smith
-
依托单位:
Alzhelmer's Disease Drug Development Program
-
批准号:7882501
-
项目类别:
-
资助金额:$63.43万
-
财政年份:2008
-
负责人:Amos B Smith
-
依托单位:
Alzhelmer's Disease Drug Development Program
-
批准号:8287605
-
项目类别:
-
资助金额:$59.19万
-
财政年份:2008
-
负责人:Amos B Smith
-
依托单位:
Pilot-Scale Libraries for High-throughput Screening
-
批准号:7291136
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2007
-
负责人:Amos B Smith
-
依托单位:
Pilot-Scale Libraries for High-throughput Screening
-
批准号:7684229
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2007
-
负责人:Amos B Smith
-
依托单位:
2D IR OF UNUSUAL ISOTOPOMERS AND FOLDING
-
批准号:7598434
-
项目类别:
-
资助金额:$2.78万
-
财政年份:2007
-
负责人:Amos B Smith
-
依托单位:
Pilot-Scale Libraries for High-throughput Screening
-
批准号:7497036
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2007
-
负责人:Amos B Smith
-
依托单位:
NMR systems : 2 Bruker Avance 500 Consoles
-
批准号:7225664
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2006
-
负责人:Amos B Smith
-
依托单位:
NMR SYSTEMS : 2 BRUKER AVANCE 500 CONSOLES
-
批准号:7335176
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2006
-
负责人:Amos B Smith
-
依托单位:
SYNTHESIS OF DYE LABELED LINKERS FOR PEPTIDES
-
批准号:6976506
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2004
-
负责人:Amos B Smith
-
依托单位:
SYNTHESIS OF CHLOROPEPTINS, GP120 CD4 BINDING INHIBITORS
-
批准号:6181324
-
项目类别:
-
资助金额:$21.41万
-
财政年份:1999
-
负责人:Amos B Smith
-
依托单位:
SYNTHESIS OF CHLOROPEPTINS, GP120 CD4 BINDING INHIBITORS
-
批准号:6386826
-
项目类别:
-
资助金额:$22.04万
-
财政年份:1999
-
负责人:Amos B Smith
-
依托单位:
SYNTHESIS OF CHLOROPEPTINS, GP120 CD4 BINDING INHIBITORS
-
批准号:2908998
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1999
-
负责人:Amos B Smith
-
依托单位:
Understanding Envelope Function in HIV-1 Infection: The Design, Synthesis and Validation of Small Molecule HIV-1 Env Inhibitors
-
批准号:10240543
-
项目类别:
-
资助金额:$30.34万
-
财政年份:1997
-
负责人:Amos B Smith
-
依托单位:
Design and Synthesis of HIV-1 Protease Inhibitors
-
批准号:6510753
-
项目类别:
-
资助金额:$25.97万
-
财政年份:1997
-
负责人:Amos B Smith
-
依托单位:
Design and Synthesis of HIV-1 Protease Inhibitors
-
批准号:6327163
-
项目类别:
-
资助金额:$25.37万
-
财政年份:1997
-
负责人:Amos B Smith
-
依托单位:
海外基金